| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |